ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
62,536.14
-0.90%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Amarin Corp PLC (AMRN)

  7. Amarin Corp PLC (AMRN) 뉴스

AMRN

Amarin (AMRN)

Amarin Corp PLC
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AMRN
일자시간출처헤드라인심볼기업
2024/04/2503:00GlobeNewswire Inc.Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular EventNASDAQ:AMRNAmarin Corp PLC
2024/04/2221:00GlobeNewswire Inc.Amarin Announces Results of Annual General Meeting of ShareholdersNASDAQ:AMRNAmarin Corp PLC
2024/04/1521:00GlobeNewswire Inc.Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024NASDAQ:AMRNAmarin Corp PLC
2024/04/0821:00GlobeNewswire Inc.Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24NASDAQ:AMRNAmarin Corp PLC
2024/04/0819:30PR Newswire (Canada)New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient SubgroupsNASDAQ:AMRNAmarin Corp PLC
2024/04/0704:30GlobeNewswire Inc.New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient SubgroupsNASDAQ:AMRNAmarin Corp PLC
2024/04/0321:00GlobeNewswire Inc.Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in EuropeNASDAQ:AMRNAmarin Corp PLC
2024/03/2521:00GlobeNewswire Inc.Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & ExpoNASDAQ:AMRNAmarin Corp PLC
2024/03/0507:30Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AMRNAmarin Corp PLC
2024/03/0422:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AMRNAmarin Corp PLC
2024/02/2921:06Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AMRNAmarin Corp PLC
2024/02/2921:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMRNAmarin Corp PLC
2024/02/2921:00GlobeNewswire Inc.Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:AMRNAmarin Corp PLC
2024/02/1522:00GlobeNewswire Inc.Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024NASDAQ:AMRNAmarin Corp PLC
2024/02/1222:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AMRNAmarin Corp PLC
2024/02/1006:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/02/1006:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/02/1006:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/02/0306:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/02/0306:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/02/0306:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/01/2621:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMRNAmarin Corp PLC
2024/01/2506:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/01/2221:30GlobeNewswire Inc.Amarin Chairman & CEO Issue Letter to ShareholdersNASDAQ:AMRNAmarin Corp PLC
2024/01/1307:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/01/1307:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/01/1307:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
2024/01/1021:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMRNAmarin Corp PLC
2024/01/1021:00GlobeNewswire Inc.Amarin Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024NASDAQ:AMRNAmarin Corp PLC
2024/01/0908:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
 검색 관련기사 보기:NASDAQ:AMRN

최근 히스토리

CCOM
SILVER
SILVER
PM
XAUUSD
Gold vs US Dollar
NYSE
MRK
Merck
FX
USDEUR
US Dollar vs Euro
NYSE
XOM
Exxon Mobil
NYSE
DIS
Walt Disney
CCOM
US100
US Tech 100
CCOM
US30
US 30
AMEX
SPY
SPDR S&P 500
SPI
SP500
S&P 500
USOTC
RHHBY
Roche (QX)
NASDAQ
NVDA
NVIDIA
NYSE
BAC
Bank of America
NASDAQ
TSLA
Tesla
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유